BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21420940)

  • 1. Differential regulation of 5-HT2A receptor mRNA expression following withdrawal from a chronic escalating dose regimen of D-amphetamine.
    Horner KA; Gilbert YE; Noble ES
    Brain Res; 2011 May; 1390():10-20. PubMed ID: 21420940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress and withdrawal from d-amphetamine alter 5-HT2A receptor mRNA expression in the prefrontal cortex.
    Murray RC; Hebbard JC; Logan AS; Vanchipurakel GA; Gilbert YE; Horner KA
    Neurosci Lett; 2014 Jan; 559():44-9. PubMed ID: 24287377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
    Horner KA; Noble ES; Lauterbach EC
    Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF; Tan YY; Huang X; Wang Q
    Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
    Fuller JJ; Murray RC; Horner KA
    Neuropharmacology; 2015 Oct; 97():7-17. PubMed ID: 25986696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering the mechanisms underlying serotonin (5-HT)2A and 5-HT2C receptor regulation following nicotine withdrawal in rats.
    Zaniewska M; Alenina N; Wydra K; Fröhler S; Kuśmider M; McCreary AC; Chen W; Bader M; Filip M
    J Neurochem; 2015 Aug; 134(4):704-16. PubMed ID: 26031442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Proenkephalin mRNA expression in forebrain areas after amphetamine-induced behavioural sensitization.
    Morales-Mulia M; Panayi F; Lambás-Señas L; Scarna H; Méndez M
    Pharmacol Biochem Behav; 2007; 87(2):232-40. PubMed ID: 17537495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 2A and 2C receptor biosynthesis in the rodent striatum during postnatal development: mRNA expression and functional linkage to neuropeptide gene regulation.
    Basura GJ; Walker PD
    Synapse; 2000 Nov; 38(2):216-25. PubMed ID: 11018795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Han M; Storlien LH
    Brain Res Mol Brain Res; 2004 Aug; 127(1-2):39-47. PubMed ID: 15306119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A region-specific increase in Galphaq and Galpha11 proteins in brains of rats during cocaine withdrawal.
    Carrasco GA; Zhang Y; Damjanoska KJ; D'Souza DN; Garcia F; Battaglia G; Muma NA; Van de Kar LD
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1012-9. PubMed ID: 14534355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress.
    Persico AM; Schindler CW; Zaczek R; Brannock MT; Uhl GR
    Synapse; 1995 Mar; 19(3):212-27. PubMed ID: 7784961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
    Vacca G; Ahn S; Phillips AG
    Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [8-OH-DPAT modulates expression of 5-HT(1A)/5-HT(2A), 17beta-estradiol receptor mRNAs in ovariectomized rats in Porsolt test].
    Fedotova IuO; Platonova NA; Sapronov NS
    Eksp Klin Farmakol; 2006; 69(3):53-7. PubMed ID: 16878502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
    Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain.
    Osterlund MK; Halldin C; Hurd YL
    Synapse; 2000 Jan; 35(1):39-44. PubMed ID: 10579806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases in [(3)H]-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor binding and mRNA expression of AMPA-sensitive glutamate receptor A (GluR-A) subunits in rats withdrawn from butorphanol.
    Lee SY; Jang CG
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2163-74. PubMed ID: 16326431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats.
    Xie H; Dong ZQ; Ma F; Bauer WR; Wang X; Wu GC
    Brain Res; 2008 May; 1210():76-83. PubMed ID: 18417104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.